FDA Approves Two-In-One Diabetes Treatment For Type 2

By Brenda Neugent

The U.S. Food and Drug Administration recently approved a two-in-one diabetes treatment that combines two type 2 treatments.

Glyxambi combines empagliflozin, a sodium glucose cotransporter-2 inhibitor that blocks the absorption of excess glucose by the kidneys so …

Diabetes Health Type 1: The Knock Out Boxer

My diabetic educator fired up a video of professional athletes enjoying their chosen sport. A cyclist whizzed down mountainous trails in California with an insulin pump mounted on his hip. A swimmer dove into a pool and came up just …

Translate »